Assyro AI

FDA Orange Book · active-ingredient family

Benzphetamine hydrochloride

Benzphetamine hydrochloride is approved as 1 brand and 9 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DIDREX · NDA 012427

1

Brand (NDA)

9

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
DIDREXRLD×2PFIZERNDA 012427Approved Prior to Jan 1, 1982

Generic (ANDA) products (9)

ProductApplicantApplicationTEApproved
BENZPHETAMINE HYDROCHLORIDEEPIC PHARMA LLCANDA 090346AADec 15, 2015
BENZPHETAMINE HYDROCHLORIDE×2TEDOR PHARMANDA 040747Nov 20, 2015
BENZPHETAMINE HYDROCHLORIDEAVET LIFESCIENCESANDA 202061Jan 27, 2012
BENZPHETAMINE HYDROCHLORIDE×2CHARTWELLANDA 090473Sep 15, 2010
BENZPHETAMINE HYDROCHLORIDEKVK TECHANDA 090968AAJul 20, 2010
BENZPHETAMINE HYDROCHLORIDEIMPAX LABSANDA 040845Nov 18, 2008
BENZPHETAMINE HYDROCHLORIDEEPIC PHARMA LLCANDA 040714Oct 29, 2007
BENZPHETAMINE HYDROCHLORIDESPECGX LLCANDA 040773Apr 25, 2007
BENZPHETAMINE HYDROCHLORIDESCINOPHARM TAIWANANDA 040578Apr 17, 2006

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Benzphetamine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.